Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 103.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 5,041
  • Market Cap: £87.22m
  • RiskGrade: 196

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
51.60% above the market average51.60% above the market average51.60% above the market average51.60% above the market average51.60% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
1yr Revenue Growth
64.93% above the market average64.93% above the market average64.93% above the market average64.93% above the market average64.93% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
22.01% above the market average22.01% above the market average22.01% above the market average22.01% above the market average22.01% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Book Ratio
47.3% below the market average47.3% below the market average47.3% below the market average47.3% below the market average47.3% below the market average
6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
19.19% below the market average19.19% below the market average19.19% below the market average19.19% below the market average19.19% below the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average
Price Chg 3m
64.71% above the market average64.71% above the market average64.71% above the market average64.71% above the market average64.71% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.71% below the market average11.71% below the market average11.71% below the market average11.71% below the market average11.71% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average
Momentum 20
32.37% below the market average32.37% below the market average32.37% below the market average32.37% below the market average32.37% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
21.92% below the market average21.92% below the market average21.92% below the market average21.92% below the market average21.92% below the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
ROCE
77.13% below the market average77.13% below the market average77.13% below the market average77.13% below the market average77.13% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
12.61% below the market average12.61% below the market average12.61% below the market average12.61% below the market average12.61% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
25.02% below the market average25.02% below the market average25.02% below the market average25.02% below the market average25.02% below the market average
12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average12.50% above the sector average
Operating Profit Loss
9.49% below the market average9.49% below the market average9.49% below the market average9.49% below the market average9.49% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
5.47% above the market average5.47% above the market average5.47% above the market average5.47% above the market average5.47% above the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
Cash
28.95% above the market average28.95% above the market average28.95% above the market average28.95% above the market average28.95% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
66.83% above the market average66.83% above the market average66.83% above the market average66.83% above the market average66.83% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
14.84% below the market average14.84% below the market average14.84% below the market average14.84% below the market average14.84% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 103.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 109.00
52 Week Low 80.50
Volume 5,041
Shares Issued 84.68m
Market Cap £87.22m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.38% below the market average90.38% below the market average90.38% below the market average90.38% below the market average90.38% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Price Trend
40.91% above the market average40.91% above the market average40.91% above the market average40.91% above the market average40.91% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Income Not Available
Growth
5.32% above the market average5.32% above the market average5.32% above the market average5.32% above the market average5.32% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Diaceutics Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
12:34 40 @ 103.00p
10:19 5,000 @ 102.00p
09:33 1 @ 102.12p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page